Evidence map›Paper›PMID 38315732›Full record

ArticlePloS one2024

Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.

Nathalie MacKinnon, Daniel Lane, Frank Scheuermeyer, Janusz Kaczorowski, Kathryn Dong, Aaron M Orkin, Raoul Daoust, Jessica Moe, Gary Andolfatto, Michelle Klaiman and 9 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nathalie MacKinnonDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Daniel LaneDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-8600-8895
Frank ScheuermeyerDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Janusz KaczorowskiUniversité de Montréal, Montreal, Quebec, Canada.
Kathryn DongDepartment of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada.
Aaron M OrkinDepartment of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-1111-8720
Raoul DaoustUniversité de Montréal, Montreal, Quebec, Canada.
Jessica MoeDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Gary AndolfattoDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Michelle KlaimanDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Justin YanDivision of Emergency Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Justin J KohDepartment of Emergency Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Kathryn CrowderDepartment of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.
Paul AtkinsonDepartment of Emergency Medicine, Dalhousie University, St. John, New Brunswick, Canada.
David SavageDivision of Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
James StempienDepartment of Emergency Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Floyd BessererDepartment of Emergency Medicine, University of British Columbia, Prince George, British Columbia, Canada.
Jason WaleDepartment of Emergency Medicine, University of British Columbia, Victoria, British Columbia, Canada.
Andrew KestlerDepartment of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9358-0272

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify individual and site-related factors associated with frequent emergency department (ED) buprenorphine/naloxone (BUP) initiation. BUP initiation, an effective opioid use disorder (OUD) intervention, varies widely across Canadian EDs.

methodsWe surveyed emergency physicians in 6 Canadian provinces from 2018 to 2019 using bilingual paper and web-based questionnaires. Survey domains included BUP-related practice, demographics, attitudes toward BUP, and site characteristics. We defined frequent BUP initiation (the primary outcome) as at least once per month, high OUD prevalence as at least one OUD patient per shift, and high OUD resources as at least 3 out of the following 5 resources: BUP initiation pathways, BUP in ED, peer navigators, accessible addiction specialists, and accessible follow-up clinics. We excluded responses from sites with <50% participation (to minimize non-responder bias) and those missing the primary outcome. We used univariate analysis to identify associations between frequent BUP initiation and factors of interest, stratifying by OUD prevalence.

resultsWe excluded 3 responses for missing BUP initiation frequency and 9 for low response rate at one ED. Of the remaining 649 respondents from 34 EDs, 374 (58%) practiced in metropolitan areas, 384 (59%) reported high OUD prevalence, 312 (48%) had high OUD resources, and 161 (25%) initiated BUP frequently. Age, gender, board certification and years in practice were not associated with frequent BUP initiation. Site-specific factors were associated with frequent BUP initiation (high OUD resources [OR 6.91], high OUD prevalence [OR 4.45], and metropolitan location [OR 2.39],) as were individual attitudinal factors (willingness, confidence, and responsibility to initiate BUP.) Similar associations persisted in the high OUD prevalence subgroup.

conclusionsIndividual attitudinal and site-specific factors were associated with frequent BUP initiation. Training to increase physician confidence and increasing OUD resources could increase BUP initiation and benefit ED patients with OUD.

Indexed as

BuprenorphineOpioid-Related DisordersBuprenorphine, Naloxone Drug CombinationCanadaCognitionEmergency Service, HospitalHumansNaloxoneNarcotic AntagonistsBuprenorphineBuprenorphine, Naloxone Drug CombinationNaloxoneNarcotic Antagonists

Identifiers

PMID38315732
PMCPMC10843078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.